Proximed

Quick links to important sections

Proximed

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proximed

Quick Facts: Proximed Identity

Property Description
Active Ingredient Proglumetacin (INN)
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Origin / Type Synthetic Prodrug
Key Forms Capsules, Suppositories, Solution for Injection
General Purpose Relief of pain, inflammation, and fever

Proximed: Definition and Pharmacological Identity

Proximed is a medicinal preparation that contains the active substance Proglumetacin, which is formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This classification is clinically recognized for its anti-inflammatory and pain-relieving capabilities, placing it within the group of anti-rheumatic and anti-inflammatory agents. Proximed is a prescription-only, single-ingredient synthetic product positioned for adults managing inflammatory conditions.


Composition and Prodrug Concept

The chemical structure of Proglumetacin defines it as a prodrug; it is largely inactive upon administration and is designed to be converted by the body's metabolic processes into the potent, established active therapeutic agent, Indomethacin. The molecular identity and prodrug status of Proglumetacin are defining features of its composition. This prodrug mechanism facilitates a specific pharmacokinetic profile for the release of Indomethacin, a compound known for its strong anti-inflammatory effects. Proximed is available in several forms, including oral capsules, suppositories for rectal use, and a sterile solution for intramuscular injection, providing flexibility for administration.


General Therapeutic Purpose

As an NSAID, the core purpose of Proximed is to help relieve the cardinal symptoms that arise from inflammatory states. The medication is generally used in scenarios such as managing the discomfort, stiffness, and localized swelling associated with chronic musculoskeletal issues. By modulating the chemical mediators that cause these symptoms, the medication provides simultaneous analgesic (pain-relieving), anti-inflammatory (swelling-reducing), and antipyretic (fever-reducing) effects, offering systemic relief.

What side effects are possible with Proximed?

Possible Side Effects and Safety Information

The safety profile for Proximed, as documented by government regulatory bodies, classifies adverse events by the body system affected and their reported frequency in clinical data.

Commonly Reported Adverse Reactions

Adverse events reported as common include those affecting the Gastrointestinal System (such as nausea, vomiting, loss of appetite, and diarrhea) and Skin/Subcutaneous Tissues (including rash and hives). These are generally the most frequent side effects observed.

Serious and Life-Threatening Reactions

Official regulatory labeling highlights the potential for serious and fatal adverse reactions. These include severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Other significant safety risks include severe blood disorders (e.g., agranulocytosis, aplastic anemia, or severe neutropenia), acute liver necrosis, and acute respiratory failure. In some cases, initial symptoms such as a skin rash, fever, cough, or sore throat may be early indications of a severe reaction.

Population-Specific Safety Considerations

  • Pediatric Patients: Use is contraindicated in infants under two months of age. Limited data exists on the safety of repeated use in children under two years old.
  • Geriatric Patients: Older adults may have an increased risk for severe adverse effects, particularly high potassium levels (hyperkalemia) and serious skin reactions, often due to underlying conditions like impaired kidney or liver function.
  • Pregnancy and Breastfeeding: Regulatory documents note that use during pregnancy may be associated with an increased risk of certain birth defects. Both components pass into human milk, and risks must be evaluated.

Restrictions and Limitations

Proximed is formally contraindicated in patients with a history of hypersensitivity to the drug's components, documented megaloblastic anemia due to folate deficiency, severe kidney insufficiency, or marked liver damage. Caution is warranted in patients with pre-existing conditions such as certain kidney or liver issues, folate deficiency, HIV/AIDS, or conditions that increase the risk of electrolyte imbalances.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations and mandated emergency actions for overdose, based on regulatory information for this Non-Steroidal Anti-Inflammatory Drug (NSAID) class.

Overdose Scope Official Regulatory Information
Documented Overdose Presentations Symptoms may include Gastrointestinal Distress (Nausea, Vomiting, Epigastric Pain) and Central Nervous System effects (Drowsiness, Lethargy, Confusion, Severe Headache).
Physiological Systems Affected Severe toxicity involves the Gastrointestinal System (potential for Ulceration, Bleeding, Perforation), the Renal System (potential for Acute Renal Failure), and the CNS (potential for Convulsions or Coma).
Population-specific Overdose Notes Elderly patients are documented to have an increased risk of severe adverse outcomes, including gastrointestinal hemorrhage and renal impairment.
Emergency-Response Statements Contact emergency services or a national Poison Control Center immediately upon suspicion of a large ingestion. Seek immediate medical attention for symptoms such as chest pain, sudden weakness, or slurred speech.

Overdose Classifications

  • Severity Classification: Overdose is classified by the potential for severe outcomes, including acute organ dysfunction and neurological complications.
  • Overdose-Context Constraints: No specific antidote is known for this medication. Management procedures are limited to symptomatic and supportive care, including monitoring and clinical investigation.

Connection to the overall overdose profile: Regulatory documents explicitly define the overdose profile through a limited cluster of documented clinical signs and the potential for life-threatening outcomes affecting the neurological, renal, and gastrointestinal systems. This framework mandates that individuals must seek immediate medical help upon suspicion of overdose, as management relies entirely on supportive care and rigorous hospital monitoring to address these defined risks.

Therapeutic Uses of Proximed

What Proximed Treats: Main Uses and Benefits

Proximed (Proglumetacin) is generally used in situations involving certain distressing symptoms related to inflammatory or irritative states. Non-aspirin NSAIDs are generally indicated for pain, especially due to inflammation and tissue injury, and for inflammatory arthropathies like rheumatoid arthritis and osteoarthritis.

The medication is commonly used across conditions characterized by episodic or fluctuating symptom patterns. It is applied in addressing symptom clusters that include persistent joint pain, restrictive morning stiffness, and localized swelling.

Chronic and Acute Symptom Management

This medication is relevant across conditions such as Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis, and specific soft tissue disorders like bursitis and tendinopathy. It is also often used when symptoms intensify and supportive relief is needed, for instance, in postoperative pain management or regional syndromes where symptoms create noticeable functional strain, such as low-back pain.

This support helps ease the overall symptom load and may assist with maintaining a sense of stability when symptoms are more noticeable during long-term management.


Quick Fact: Relief for Key Symptoms
Proximed may assist with managing symptoms related to physical discomfort and inflammatory or irritative states across chronic and acute musculoskeletal conditions.

Regulatory References

  1. Therapeutic Goods Administration (TGA) safety review

Eligibility and Restrictions for Use

Proximed (Proglumetacin) eligibility is defined by a strict set of rules, particularly due to its classification as an NSAID prodrug of Indomethacin. Use is primarily established for Adults managing inflammatory conditions.

The medicine is Contraindicated in patients with a known hypersensitivity to Proglumetacin, its active metabolite Indomethacin, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID). Absolute prohibitions also apply to individuals with active gastrointestinal ulceration or hemorrhage, a history of aspirin-sensitive asthma, or those undergoing Coronary Artery Bypass Graft (CABG) surgery.

Severe renal impairment and severe hepatic impairment are also formal contraindications. Furthermore, use is Contraindicated in pregnant women starting at 30 weeks gestation due to fetal risk, and is not recommended during breastfeeding. Use between 20 and 30 weeks gestation should be strictly limited.

Regarding age, use is not established in pediatric patients. Older adults are flagged as a high-risk group, requiring conditional use at the lowest effective dose.

What should I know about interactions with other medicines?

Proximed's interaction profile is established by regulatory documents based on its conversion to the active therapeutic agent, Indomethacin. Official restrictions classify its use as contraindicated in the setting of peri-operative pain for Coronary Artery Bypass Graft (CABG) surgery. Additionally, co-administration with analgesic doses of Aspirin is not generally recommended due to documented additive risks of serious gastrointestinal adverse events.

The product’s interactions are broadly classified by regulatory sources as pharmacodynamic interference or pharmacokinetic modification.

Pharmacodynamic Interference and Restrictions

Pharmacodynamic interference is documented to occur with antihypertensive agents (including ACE Inhibitors and ARBs) and diuretics, potentially diminishing their efficacy. Co-administration with drugs that interfere with hemostasis, such as Warfarin or SSRIs, increases the documented risk of bleeding. The combination of Proximed with other NSAIDs carries an increased risk of gastrointestinal complications.

Pharmacokinetic Modification

Pharmacokinetic modification is noted for several specific medicines, including Lithium, Digoxin, and Methotrexate, where co-administration may increase the serum concentration and prolong the half-life of these drugs. The regulatory documents advise that close monitoring of serum levels is required when these combinations are used. For all documented interactions, the regulatory label does not specify mandatory timing separation rules.

Population-Specific Constraint

A population-specific constraint exists for co-administration with ACE Inhibitors or ARBs: the risk of renal function deterioration is heightened in elderly, volume-depleted, or renally impaired patients.

Mechanism of Action

How Proximed Works

The mechanism of action for Proximed is based on the activity of its active metabolite, Indomethacin, and its co-metabolite, Proglumide. Indomethacin acts as a non-selective inhibitor of Cyclooxygenase (COX-1 and COX-2) enzymes. This binding interrupts the arachidonic acid cascade, thereby preventing the synthesis of Prostaglandin E2 ( PGE2) and other lipid mediators associated with regulating local inflammatory processes and the body's thermoregulatory set point. The parent compound also restricts the formation of leukotrienes by influencing the 5-Lipoxygenase (5-LOX) pathway.

By reducing PGE2 levels, the mechanism limits the chemical sensitization of peripheral nociceptors and causes the re-setting of the hypothalamic temperature set point, which influences thermoregulation. Additionally, the Proglumide component acts as an antagonist of Cholecystokinin (CCK) receptors, thereby modulating the pathway that stimulates gastric acid secretion, resulting in a parallel physiological effect alongside the core enzyme inhibition.

Dosage and Administration Information

How to Use Proximed

The usage of Proximed (Proglumetacin) is defined by its administration routes and adherence to the dosing principles established for its active metabolite, Indomethacin. The medicine is available in three forms: capsules for oral use, suppositories for rectal administration, and a solution for injection for intramuscular (IM) use, providing flexibility in clinical practice.


Administration and Scheduling Principles

The medication is utilized at the lowest effective dosage for the shortest duration consistent with individual treatment goals.

For chronic maintenance therapy, such as in long-term inflammatory conditions, dosing begins at a low level and involves gradual upward adjustment over weekly intervals. The total daily dosage of the active moiety should generally not exceed 200 mg. Administration is typically structured as divided daily doses (multiple times per day).

In contrast, use for acute conditions like flare-ups or tendinitis is a time-limited course, often lasting between 7 and 14 days, with the expectation of discontinuation once the symptoms are under control. The largest portion of the total daily dose may be scheduled at bedtime to specifically address pain and stiffness that worsen overnight.

Special Population Consideration: The use of Proximed requires greater care in older adults, due to increased sensitivity to the active ingredient.

Recent Clinical Evidence

Research evidence / Overview of studies for Proximed


Research Contexts for Proximed: Conditions with Episodic Manifestations

What the Studies Explored

Research was studied for conditions characterized by fluctuating or episodic manifestations. These studies were conducted during periods of increased symptom activity and focused on the measurement of outcomes over short, defined time intervals. The primary focus of the research was observed in trials that looked at outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort. Essentially, research examined how symptoms were reported in research contexts involving fluctuating symptoms.

What the Findings Suggest

Findings describe the symptom patterns observed in the study populations. For the specific conditions studied for, the data show patterns related to the symptom patterns observed over the defined time intervals when patients was observed in the study. Specifically, some data show patterns related to outcomes reflecting daily functioning or activity level, which were assessed. It is important to remember that these findings describe group patterns, not personal outcomes.

Remaining Questions and Study Limitations

Studies indicate that research describes patterns related to short-term changes, but a number of limitations must be acknowledged. For this area of study, long-term effects are not fully established, and follow-up durations were limited in many of the key studies. Additionally, sample sizes were modest in certain analyses, meaning the results apply only to the populations studied and further research is ongoing to better understand the observed patterns. There is limited information for long-term outcomes.


Research Contexts for Proximed: Conditions Associated with Systemic or Functional Imbalance

What the Studies Explored

Proximed was evaluated in a separate series of studies applied in research contexts involving fluctuating or unstable symptoms associated with conditions involving periods of heightened symptoms. These studies explored the measurement of outcomes related to outcomes related to systemic or functional imbalance and outcomes linked to inflammatory or irritative states. The research examined temporary physiological imbalance and how individuals reported their experiences during those periods. The research approach focused on settings evaluating daily-life functioning in the observed populations.

What the Findings Suggest

In these specific trials, the research describes changes measured during the study period for some individuals. The data show patterns related to outcomes monitoring physiological strain or stress. However, in this area of study, the findings were mixed, and it was observed in some studies that the measured changes and the patient-reported outcomes varied. Research does not determine whether an individual will respond similarly to the group findings.

Remaining Questions and Study Limitations

The evidence quality varies across studies for this specific focus. Data are still emerging, and comparative evidence is lacking for certain patient groups. Specifically, subgroup findings are uncertain, and data for certain groups remain insufficient to draw broad conclusions. Therefore, certainty remains low when considering the full scope of evidence. Studies help show what has been observed so far, but evidence highlights what is known — and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about Proximed (FAQ)

Q: Is Proximed a long-term medicine, or is it used for a short time only?

A: Official information indicates that Proximed may be prescribed for both long-term chronic maintenance therapy in certain conditions and as a time-limited course (e.g., 7 to 14 days) for acute issues. In both cases, regulatory documents advise using the lowest effective dosage for the shortest duration necessary.

Q: Does Proximed interact with common over-the-counter pain relievers like ibuprofen?

A: Regulatory documents state that taking Proximed with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is generally not recommended. This group includes common over-the-counter pain relievers such as ibuprofen. Combining Proximed with other NSAIDs carries an increased, documented risk of serious gastrointestinal side effects.

Q: Is Proximed safe for use by older adults, generally speaking?

A: Official product information states that Proximed should be used with greater care in older adults. This is because advancing age may lead to an increased possibility of adverse reactions, particularly high potassium levels (hyperkalemia) and severe skin issues, often due to underlying health conditions.

Q: Is there research evidence suggesting Proximed is effective for its main use?

A: Studies and official information indicate that Proximed (Indomethacin) provided significant relief from symptoms associated with its main uses, such as pain, inflammation, and stiffness, when compared to a placebo in specific patient populations studied for conditions like arthritis and acute shoulder pain. These findings describe group patterns observed in clinical trials.

Q: Does taking Proximed require any special monitoring or tests?

A: Regulatory documents advise that general monitoring of renal function may be required in high-risk patients (such as the elderly or those with existing kidney issues). Additionally, close monitoring of serum concentrations is necessary when Proximed is taken alongside certain medicines like Lithium, Digoxin, and Methotrexate.

Q: Are there specific warnings about Proximed and high blood pressure?

A: Official documents warn that NSAIDs, which includes Proximed, can potentially cause the new onset of hypertension (high blood pressure) or worsen existing hypertension. For this reason, official information advises that a patient’s blood pressure and cardiovascular status are typically monitored during treatment.

Q: Can Proximed be taken with other prescription heart medicines?

A: Proximed has been documented to interact with certain prescription heart medicines. For example, it may diminish the efficacy of some antihypertensive agents, such as ACE Inhibitors and ARBs, and diuretics. Official information notes that Proximed can also worsen heart failure and advises caution when it is used alongside Digoxin.

Q: What is the main difference between Proximed and other medicines used for the same purpose?

A: Proximed is chemically classified as a prodrug, meaning it is largely inactive until the body's metabolism converts it into the potent therapeutic agent, Indomethacin. It also produces a component called Proglumide, which has an additional action that may help modulate gastric acid secretion, which differentiates it from some other NSAIDs.

Q: Can Proximed cause weight gain, or is that a common side effect?

A: Official information states that NSAIDs, including Proximed, can cause fluid retention and edema. This fluid buildup may lead to sudden, temporary weight gain and is listed as an adverse effect that is typically monitored during treatment.

Q: How quickly should a person expect to notice the effects of Proximed?

A: Clinical studies provide an indication of the expected onset of relief for some acute conditions. For example, for acute pain such as from gout, definitive relief has been reported in studies within 2 to 4 hours of administration, with most symptoms subsiding within a few days.

Q: Is it common to feel tired or dizzy when first starting Proximed?

A: Regulatory documents list central nervous system (CNS) effects, including dizziness and headache, as common adverse reactions. Uncommon effects like unusual drowsiness or listlessness are also reported during clinical use.

Q: Can Proximed affect blood sugar levels, even if a person does not have diabetes?

A: Though rare, changes in blood sugar have been documented as adverse reactions associated with Proximed. Official information describes reports of both hyperglycemia (high blood sugar) and glycosuria (glucose in the urine) in clinical use.

Q: Is there a maximum amount of time Proximed is studied to be taken for?

A: For acute, short-term inflammatory conditions like painful shoulder (bursitis/tendinitis), the prescribed course of therapy is typically defined as 7 to 14 days. For chronic conditions, patients should be maintained on the smallest effective dose, but official documents note that long-term effects are not fully established for all conditions.

Q: Can taking Proximed cause issues with sleep or insomnia?

A: Yes, regulatory documents list insomnia and nervousness as documented adverse reactions reported during clinical use.

Q: Is Proximed thought to have any impact on mood or energy levels?

A: Regulatory documents report adverse reactions affecting the central nervous system. These documented effects include changes in mood or energy such as depression, listlessness, anxiety, and psychic disturbances.

Q: What are the potential effects of combining Proximed with alcohol?

A: Official warnings state that the combination of Proximed with alcohol significantly increases the documented risk of serious gastrointestinal side effects, including stomach bleeding.

Q: Do studies suggest Proximed's effect lasts for a full 24 hours?

A: The immediate-release form of Proximed is typically scheduled as divided doses taken multiple times per day. Official documents mention the availability of an extended-release capsule form, which is specifically designed for once or twice daily use.

Q: Does Proximed have a risk of dependence or withdrawal described in official sources?

A: Proximed (Indomethacin) is not classified as a controlled substance by U.S. federal regulatory agencies. Furthermore, dependence or a high potential for misuse is not listed as a known risk in official product information.

Q: Can Proximed interfere with the results of any common lab tests?

A: Official documents describe that Proximed can interfere with the results of some tests. This interference may involve tests that monitor renal function (kidney function) and certain tests for serum concentrations of other medications, such as Lithium.

Q: Are there any restrictions on driving or operating machinery while on Proximed?

A: Yes, because Proximed can cause central nervous system effects like dizziness and drowsiness, regulatory documents caution against engaging in activities requiring full mental alertness. This includes driving a car or operating hazardous machinery.

Q: Does Proximed carry a specific boxed warning from a regulatory agency?

A: Yes, official regulatory documents state that Proximed (Indomethacin) carries a Boxed Warning. This warning highlights the risks of serious, potentially fatal cardiovascular thrombotic events (such as heart attack and stroke) and serious gastrointestinal adverse events (such as bleeding and ulceration).

Q: What happens to Proximed in the body (absorption/elimination) as described in official documents?

A: Official pharmacokinetic information describes that Proximed is rapidly absorbed after administration. It is then extensively metabolized by the liver, converting it into its active form, Indomethacin, and other inactive compounds, which are primarily eliminated through both urine and feces.

Q: Are there different versions or strengths of Proximed available?

A: Regulatory documents list that Proximed is available in various forms and strengths. This includes immediate-release capsules, extended-release capsules, suppositories for rectal use, and a suspension or solution for injection.

Q: Are there any reports about Proximed affecting fertility or reproductive health?

A: Based on its mechanism of action as an NSAID, official documents state that Proximed may be associated with a reversible delay in ovulation (the release of an egg). This is noted as a factor to consider for women who are experiencing difficulties in becoming pregnant.

Q: Is it acceptable to crush or split Proximed tablets?

A: Official instructions for the use of Proximed often specify that certain forms, like the extended-release capsules, should be swallowed whole. This is required so the medicine can maintain its intended release profile and deliver the dose correctly; they should not be chewed, crushed, or cut.

How should Proximed be stored and disposed of?

How to Store and Dispose of Proximed

All storage and disposal rules for Proximed are based strictly on regulatory requirements to maintain product stability and safety.


Official Storage Conditions

Proximed must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original container and maintained tightly closed to protect it from excessive moisture and light. It is mandatory to keep the medicine out of the sight and reach of children and to avoid storage in areas that may freeze or exceed the maximum temperature range.

Disposal Instructions

Do not use Proximed past the labeled expiration date. For disposal, regulatory guidance mandates the use of a drug take-back program or mail-back envelope. If these options are unavailable, the official procedure requires mixing the medicine with an undesirable substance, placing the mixture in a sealed container, and discarding it in the household trash. The medication must not be flushed down the toilet or poured into any wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proximed found in:

A-Z Index: